Overview
No overview information available.
Indication
用于治疗以下情况的缺铁：口服铁剂无效或无法口服补铁时；临床上需要快速补充铁时。缺铁诊断必须基于实验室检查。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/02/17 | Phase 4 | Not yet recruiting | Xie Jingyuan, MD | ||
2024/04/08 | Phase 4 | Recruiting | Lucie Favre | ||
2022/09/19 | N/A | Completed | |||
2022/08/17 | N/A | Active, not recruiting | |||
2022/05/03 | Phase 4 | Completed | |||
2020/04/15 | Phase 4 | UNKNOWN | |||
2019/05/21 | Phase 3 | Completed | |||
2018/08/01 | Not Applicable | Terminated | |||
2018/03/15 | Phase 4 | Completed | |||
2017/01/06 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Iron Isomaltoside Injection | 国药准字HJ20210006 | 化学药品 | 注射剂 | 1/30/2021 | |
| Iron Isomaltoside Injection | 国药准字HJ20210005 | 化学药品 | 注射剂 | 1/30/2021 | |
| Iron Isomaltoside Injection | 国药准字HJ20210007 | 化学药品 | 注射剂 | 1/30/2021 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.